Prevalence and determinants of biochemical dysfunction of the liver in Atayal Aboriginal community of Taiwan: Is betel nut chewing a risk factor? by Lin, Ching-Feng et al.
BioMed  Central
Page 1 of 8
(page number not for citation purposes)
BMC Gastroenterology
Open Access Research article
Prevalence and determinants of biochemical dysfunction of the liver 
in Atayal Aboriginal community of Taiwan: Is betel nut chewing a 
risk factor?
Ching-Feng Lin1,2,5, Tun-Jen Shiau1, Ying-Chin Ko3,4, Ping-Ho Chen4 and 
Jung-Der Wang*1
Address: 1Institute of Occupational Medicine and Industrial Hygiene, National Taiwan University, College of Public Health and Department of 
Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan, 2Department of Health, Executive Yuan, Taiwan, 3Department of Public 
Health, Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan, 4Division of Environmental Health and 
Occupational Medicine, National Health Research Institutes, Taiwan and 5School of Public Health, Taipei Medical University, Taiwan
Email: Ching-Feng Lin - baliowl@mail.bali.doh.gov.tw; Tun-Jen Shiau - adlcf@doh.gov.tw; Ying-Chin Ko - ycko@nhri.org.tw; Ping-
Ho Chen - phchen@nhri.org.tw; Jung-Der Wang* - jdwang@ntu.edu.tw
* Corresponding author    
Abstract
Background: We address the independent and interactive roles of habitual betel quid chewing
and other known risk factors for biochemical dysfunction and cirrhosis of the liver.
Methods:  To determine the prevalence rates and risk factors associated with biochemical
dysfunction of the liver, a total of 3,010 adult residents in an Atayal Aboriginal community were
invited to participate in the study. Abdominal ultrasonography was used to diagnose liver cirrhosis.
Results: There were 2,063 Atayal Aboriginal and 947 non-Aboriginal in this study. The result
showed overall prevalence rates for hepatitis B surface antigen (HBsAg) and hepatitis C virus
(HCV) were 21.2 % and 2.9 %, respectively. There were 16.5 %, 15.1 % and 22.4 % subjects with
abnormal alanine aminotransferase (ALT), aspartate aminotransferase (AST), and gamma glutamyl
transpeptidase (GGT), accordingly. Multiple logistic regression analysis showed that combined
infections with HBV and HCV presented with the highest risks with OR (odds ratio) and 95% CI
(confidence interval) of 4.2 (1.2–17.4) and 3.8 (1.0–14.1), respectively for elevation of ALT and AST;
followed by alcohol (1.7 and 3.1), male gender (1.7 and 1.6), betel quid (1.5 and 1.3), smoking (1.4
and 1.8), and aboriginal (1.4 and 1.3). There is effect-measure modification between viral infection
and betel quid chewing for increased severity of abnormal ALT elevation. Among 1,382 subjects
consenting to abdominal ultrasonography, 41(3.0%) were found to have liver cirrhosis with the
same factors associated with higher risks.
Conclusion: In addition to infections with viral hepatitis B and/or C, we found Atayal Aboriginal,
males, current smokers, drinkers and betel quid chewers were independently associated with
biochemical dysfunction and probably cirrhosis of the liver. Further study is needed to corroborate
the above hypothesis.
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Background
Health inequity and disparities have been demonstrated
to exist between Aboriginal and non-Aboriginal in the
USA, Australia, Taiwan and other countries [1]. In Aus-
tralia, for almost all disease categories, rates for Aboriginal
were higher than those for other Australians, which were
mainly attributed to the hypothesis of social and eco-
nomic inequality [2-4]. Such an inequality may result in
an increase of not only infectious diseases but also almost
every kind of diseases associated with diet, exercise pat-
terns, apathy and health behavior, such as alcohol drink-
ing, cigarette smoking, betel quid chewing and obesity
[1].
The population of Taiwan is 23 million, consisting of
Hokkien (73%), Hakka (12%), Mainland Chinese (13%),
and Aboriginal (2%) ethnic groups [5]. There are twelve
Aboriginal tribes in Taiwan and constitute approximately
460,000 Aboriginal of the Taiwanese (general) popula-
tion. Although there have been long term mixed marriage
with other ethnic groups, Taiwan Aboriginal still pre-
served their own languages, customs and social organiza-
tions. In hereditary characteristics, they are markedly
different from the rest of Taiwanese population [6]. Their
health status, as evaluated by life expectancy, mortality
rates and the prevalence and incidence of various diseases
such as accident, liver disease and other diseases, was
worse than that of the general population in Taiwan [1].
A more recent investigation indicated that the discrepancy
of life expectancy between Aboriginal and non-Aboriginal
were slightly reduced, but the life expectancy of Aborigi-
nal were on average 10 years less than that of the general
population, with a standardized mortality ratio approach-
ing 2-fold [7].
Taiwan is known for the high prevalence of chronic hepa-
titis B virus (HBV) infection, with a positive rate of 15–20
% for hepatitis B surface antigen (HBsAg) [8,9], which was
also reported among Aboriginal people [8]. The preva-
lence of hepatitis C infection was around 2–4 % [10].
Aboriginal in Taiwan were also found to have a high prev-
alence rate of alcoholism, estimated at about 20–30 %
[11,12], which may result in abnormal liver function or
even chronic liver injury. Thus, abnormal liver function in
Aboriginal people in Taiwan has usually been considered
to be virus or alcohol related.
Betel quid chewing is a prevalent habit in 10–20% of the
general population [13], and is also part of traditional
Aboriginal culture usually taken with alcohol during festi-
val or traditional ceremony in Taiwan [14]. The betel quid
prepared in Atayal aboriginal community of Taiwan is
quite different from those in other parts of the world. It
usually consists of 2 halves of a fresh areca nut (fruit of the
Areca catechu Linn.), sandwiched with a piece of the betel
leaf, and white slaked lime paste, instead of the reddish
inflorescence. Betel quid chewers generally swallow the
saliva completely, thus bathing the epithelial lining of the
upper digestive tract with the toxins released during chew-
ing. Such a practice may increase the possibility of toxic
effects of betel quid at target organs other than the oral
cavity [15]. In 2004, the International Agency for Research
on Cancer (IARC) declared chewing of betel quid, by
itself, to be a Group 1 carcinogen and the areca nut to be,
correspondingly, a Group 1 carcinogen [16]. Chewing
betel quid independently contributes to the risk of
oropharyngeal cancer [17-19], oral mucosal lesions [20],
oral leukoplakia [21], oral submucous fibrosis (OSF)
[21], liver cirrhosis [22,23], hepatocellular carcinoma
(HCC) [24], diabetes mellitus [25] and adverse outcomes
with use during pregnancy [26]. Endogenous formation
of areca-nut-derived nitrosamines was found in vivo or in
vitro  studies, suggesting that the damage of liver could
partly result from metabolite of the areca nut [27].
Chronic inflammation of the liver appears to be a risk fac-
tor for cirrhosis regardless of the underlying etiology [28-
30]. Experimental study has indicated persistent hepato-
cellular damage after chronic feeding with betel quid
[31,32]. However, the role of betel quid chewing in the
development of liver injury and/or cirrhosis, and its inter-
action with other known risk factors, have not drawn
much attention, although Lin et al and Tsai et al inde-
pendently published case-control studies with cirrhosis
and/or chronic liver diseases suspected to be associated
with this habit [22,23]. In this study we address the inde-
pendent and interactive roles of habitual betel quid chew-
ing and other known risk factors for biochemical
dysfunction and cirrhosis of the liver.
Methods
Design
There are 12 linguistically distinct Aboriginal tribes in Tai-
wan, which constitutes about 2 % of the total Taiwanese
population. They mainly reside in the eastern plains and
central mountainous area where is mainly above a height
of 500 m. The ethnic status was classified into two groups,
"Aboriginal" and "non-Aboriginal". Aboriginal were
defined when at least one of the two parents was Atayal
Aboriginal. Also, non-Aboriginal were defined when both
parents were not Atayal Aboriginal. The non-Aboriginal in
this study were mainly Hokkien and Hakka people living
in the same community. In this study, we selected the
Fushin district in Taoyuan county, which was in the catch-
ment area of our investigations and locates in the north-
ern part of Taiwan with a total of 4,665 residents who
were above 20 years of age. Every citizen in the district was
invited to participate in a comprehensive physical exami-
nation including a detailed questionnaire of health his-
tory. A total of 3,010 subjects (64.5%) responded, whichBMC Gastroenterology 2008, 8:13 http://www.biomedcentral.com/1471-230X/8/13
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included 2,063 Atayal Aboriginal and 947 non-Aborigi-
nal.
This study was first approved by the medical research eth-
ics committee of the hospitals of the Department of
Health of Taiwan before commencement, of which the
certification number is 900808-03. The informed consent
was provided both orally and in writing, which was con-
ducted under the assistance of local public health nurses
who can speak Atayal language.
Data collection and analysis
After obtaining an informed consent from every subject,
10 c.c. of blood was drawn from every respondent's ante-
cubital vein. All blood samples were centrifuged and
serum was frozen down to – 30°~-70°C until they were
tested for hepatitis B & C markers and biochemical func-
tion of the liver, including alanine aminotransferase
(ALT), aspartate aminotransferase (AST), and gamma-
glutamyltranspeptidase (GGT).
Test for HBsAg and anti hepatitis C virus (HCV) was con-
ducted by radioimmunoassy with reagents supplied by
Abbott company (U.S.A.), and read by clinical Gamma
Counter (L.K.B of U.S.A.) with both positive and negative
controls. If the reading was on the borderline, the test was
repeated 2~3 times. If it consistently showed positive,
then the result was considered positive. Liver function
tests were performed with reagents supplied by Hitachi
7400. All these serological tests were conducted in the
central laboratory of the Taoyuan general Hospital,
Department of Health. Every subject was also asked to fill
out a questionnaire containing basic demographic infor-
mation and previous medical history, ethnic group, alco-
hol drinking, smoking, betel quid chewing, blood
transfusion and intravenous injection. Every case was
physically examined by a doctor. The history of blood
transfusion and intravenous injection was verified from
the medical records of the local public health stations,
which were the only resource providing health services to
the people residing in mountainous area and the data
were with a confirmed rate of 99%. Every subject was also
invited to receive abdominal ultrasonography examina-
tion (Toshiba SAL-38B, Tokyo, Japan).
Dependent variables
Separate analyses were conducted for biochemical liver
function (ALT, AST, GGT) and liver cirrhosis. The dichot-
omous variables, biochemical liver function, were coded
as ALT (>=37; < 37)/AST (>=37; < 37)/GGT (>=61/<61).
Data was separately analyzed for risk factors associated
with biochemical liver function/liver cirrhosis. The only
one hepatologist conducted all the real time ultrasonogra-
phy and scored on 10 parameters [33], which ranged from
0, 0.5, 1(mild), 2(moderate), and 3(marked) for each
parameter. The more specific parameters for cirrhosis
included nodular liver surface, coarse echotexture, irregu-
lar narrowing of hepatic veins and a summed score of
more than 4.0 indicated cirrhosis of liver with an accuracy
of 95.6% [33].
Independent variables
Potential risk factors included ethnic group, gender, age,
body mass index (BMI), cigarette smoking, alcohol con-
sumption, betel quid use, HBsAg(+), and anti-HCV(+).
Body mass index (BMI) was calculated (BMI = weight/
height2, kg/m2). The smoking and drinking behaviors
were coded as current smokers/drinkers (continual smok-
ing/drinking least once a week, irrespective of quantity),
never smokers/drinkers/(those who never smoked/
drank), or former smokers/drinkers (those who quit
smoking/drinking at least one year prior the survey). Betel
quid chewing behavior, was coded as betel quid chewers
(chewed at least once a week, irrespective of quantity) or
never chewers (those who never chewed).
Statistical analyses
All the information of medical history and laboratory
results was collected and put into computer file and proc-
essed and analyzed by SAS version no. 6.02. A chi-square
test was performed for each univariate analysis first to
screen in potentially significant variables. Then, we calcu-
lated odds ratio (OR) with 95% CI of abnormal biochem-
ical function of the liver through multivariate modeling
after controlling major risk factors, including age, gender,
BMI, ethnic group, alcohol drinking, cigarette smoking,
betel quid chewing and hepatitis B & C status. A backward
stepwise procedure was undertaken with a selection of p-
value less than 0.001 to be kept in the final model.
Results
Originally we invited 4,665 residents who were above 20
years of age to take part in the study. Some residents did
not participate in the study, because they have already
taken jobs in urban area and moved out of the village. In
total, we successfully collected blood samples and per-
sonal information from 3,010 subjects in this Atayal Abo-
riginal community of Taiwan. Because our local public
health nurses went on door-to-door visits to every house-
hold in the community, almost all people who still
resided in the community were screened. 48 % of them
were males. Table 1 depicted the distribution of risk fac-
tors associated with abnormal liver function by using a chi
square test in the univariate analysis. The average age was
49.8 ± 10.2 years old, with about more than one third of
them in the age range of 41~60 years old (36.9%), as sum-
marized on Table 1. Among these participants, there were
2,063 (68.5%) Aboriginal, in which about one fifth
showed an abnormal ALT, 18.2% showed an abnormal
AST and 28.6% an abnormal GGT. Aboriginal consist-BMC Gastroenterology 2008, 8:13 http://www.biomedcentral.com/1471-230X/8/13
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ently showed higher proportions of smoking, alcohol
drinking, betel quid chewing, overweight, and abnormal
transminases than did non-Aboriginal. In addition, ciga-
rette smokers, alcohol drinkers, HBsAg carriers, people
with habitual betel quid chewing, and people who were
infected by HCV were found to have significantly higher
proportions of abnormal liver transaminases (all p value
< .001). The overall prevalence rates of HBsAg and anti-
HCV were 21.2 % and 2.9%, respectively.
Table 2 summarizes the results of multiple logistic regres-
sion modeling by using a backward stepwise procedure to
choose the major risk factors (p value < 0.001) of abnor-
mal biochemical liver function. After adjustment for gen-
der, BMI, viral hepatitis B and C infections, smoking,
alcohol drinking and betel quid chewing, we found that
Aboriginal were more likely to develop abnormal eleva-
tion of liver transaminases than non-Aboriginal, with an
OR of ALT 1.4 (95 % C.I., 1.2–1.7), AST 1.3 (95 % C.I.,
1.1–2.2), and GGT 1.5 (95 % C.I., 1.2–2.9). We also
found that betel quid chewing was independently associ-
ated with abnormal elevation of liver transaminases, with
an OR of ALT 1.5 (95 % C.I., 1.1–1.8) and AST 1.3 (95 %
C.I., 1.1–1.7). Current alcohol drinking increased likeli-
hood of developing abnormal elevation of liver transam-
inases after controlling other risk factors, with 4.7 times of
risk for GGT. Similarly, current smoking, male gender,
and viral hepatitis B or C infection also showed a signifi-
cantly increased likelihood of abnormal elevation of ALT,
AST, GGT after controlling other risk factors as summa-
rized on Table 2. Increased BMI (> 25) was also associated
with increased risks for abnormality in ALT and GGT.
There are linear trends for increased severity levels of ALT
elevation for both hepatitis virus infection and betel quid
chewing, and there was about 4.7 % (140/3010) of the
study population with more than 5 times of elevation of
ALT. After stratification by different levels of elevated ALT,
the multiple logistic regression analysis also showed a
synergistic effect between viral infection and betel quid
chewing, as summarized in Table 3.
Only 1382 subjects came for abdominal ultrasound
examination, which detected 41 cases (3.0 %) with cirrho-
sis of liver. Among them, 4 cases of liver cancer were sub-
sequently diagnosed and verified with pathology. All 4
cases were male Aboriginal with positive HBsAg and a
habit of alcohol drinking, except one quitted about 10
years ago. The average age of subjects with cirrhosis of
liver was 46 ± 14 years. Approximately 96 % of liver cir-
rhosis subjects had a history of alcohol drinking (12.5 %
of them have already quitted) and 45 % of them showed
positive HBsAg. After controlling for other risk factors, we
found that Aboriginal were associated with liver cirrhosis,
with an adjusted OR of 1.8 (95 % C.I., 1.4–3.2), as shown
in Table 4. Similarly, former and current alcohol drinking
increased risks of developing cirrhosis of liver with 1.6
Table 1: Frequency of demographic factors and risk factors stratified by ethnicity, and abnormal elevations of biochemical functions 
(ALT, AST, and GGT) in an Atayal aboriginal community of Taiwan
Ethnic groups
Aboriginal Nonaboriginal ALT>=37(%) AST>=37(%) GGT>=61(%)
No. of subjects 2063 947 496(16.5) * 454(15.1) * 675(22.4) *
Aboriginal 429(20.8) * 377(18.2) * 591(28.6) *
Age(year)
≤ 20 3 1 1(25.0) 0(0) 1(25.0)
21–40 732* 262 191*(19.2) 194*(19.5) 240(24.1)
41–60 743 370 211(18.9) 190(17.0) 317*(28.5)
≥ 61 585 314 93(10.3) 70(7.8) 116(12.9)
Gender
Male 992 460 357(24.5) * 321(22.1) * 508(34.9) *
Female 1071 487 139(8.9) 133(8.5) 167(10.7)
Cigarette smoking 930* 252 248(21.0) * 339(28.7) * 460(38.9) *
Alcohol drinking 1226* 267 295(19.8) * 410(27.5) * 577(38.6) *
Betel quid chewing 995* 122 399(35.7)* 375(33.6)* 290(26.0)
HBsAg(+) 441 197 153(24.0) * 147(23.1) * 154(24.1) *
Anti-HCV(+) 61 25 31(36.1) * 33(38.3) * 31(36.1) *
BMI>25 840* 277 384(34.4) * 341(30.5) 392(35.1)*
*p < 0.001 for crude chi-square test of association between individual risk factors and aboriginal ethnicityBMC Gastroenterology 2008, 8:13 http://www.biomedcentral.com/1471-230X/8/13
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Table 2: Frequency, odds ratio(OR) and 95%CI (confidence interval) for different risk factors of abnormal biochemical liver function 
estimated from multiple regression logistic model after adjustment for age, gender, and education level
Variables ALT AST GGT
No. of Cases No. of Cases No. of Cases
>=37/<37 OR (95% CI) >=37/<37 OR(95% CI) >=61/<61 OR(95% CI)
Ethnic group
Non-Aboriginal 68/868 1.0 66/870 1.0 84/852 1.0
Aboriginal 340/1724 1.4(1.2–1.7) 429/1635 1.3(1.1–2.2) 590/1472 1.5(1.2–2.9)
Alcohol drinking
Never 113/1402 1.0 85/1430 1.0 97/1417 1.0
Former 16/127 1.1(0.6–2.0) 14/129 1.0(0.5–1.9) 16/129 1.0(0.5–1.9)
Current 279/1068 1.7(1.2–2.2) 396/951 3.1(2.4–4.3) 561/951 4.7(3.3–6.0)
Cigarette smoking
Never 160/1666 1.0 156/1670 1.0 214/1612 1.0
Former 19/76 1.4(0.8–2.2) 22/73 1.7(1.2–3.1) 27/68 1.1(0.6–16)
Current 229/1068 1.4(1.1–1.8) 317/766 1.8(1.3–2.2) 433/649 1.6(1.2–2.1)
Betel quid chewing
No 117/1584 1.0 129/1613 1.0 154/1857 1.0
Yes 282/1117 1.5(1.1–1.8) 246/983 1.3(1.1–1.7) 136/527 0.7(0.5–1.1)
Gender
Female 117/1439 1.0 139/1417 1.0 167/1387 1.0
Male 291/1158 1.7(1.5–2.3) 356/1093 1.6(1.2–2.0) 507/942 2.0(1.9–2.9)
BMI
<=25 214/1659 1.0 326/1547 1.0 374/1499 1.0
>25 193/929 1.9(1.5–2.4) 167/955 1.0(0.7–1.1) 295/825 1.9(1.5–2.3)
HBV/HCV
-/- 232/971 1.0 299/1904 1.0 470/1731 1.0
+/- 132/496 1.8(1.4–2.3) 148/480 1.7(1.3–2.2) 148/480 0.8(0.6–1.0)
-/+ 27/49 3.7(3.2–9.2) 26/50 3.1(2.1–6.2) 25/51 2.0(1.3–4.4)
+/+ 5/5 4.2(1.2–17.4) 5/5 3.8(1.0–14.1) 6/4 2.3(0.7–11.0)
ALT:Alanine aminotrnsferase; AST:Alanine aminotrnsferase; GGT:γ-glutamyl transpeptidase; +:positive; -:negative; OR: odds ratio
Table 3: Frequencies and OR (odds ratio) and 95%CI (confidence interval) for betel quid chewing and infection with HBV/or HCV 
stratified by different severity levels of abnormal alanine transaminase (ALT) estimated from multiple logistic regression model after 
adjustments for alcohol and cigarette consumptions, age, ethnicity, BMI (body mass index) and gender
Levels of 
ALT 
elevation
 37 [1 ×] OR (95%CI) >37–≤111 
[1–3 ×]
OR (95%CI) >111–≤185 
[3–5 ×]
OR (95%CI) >185 [>5 ×] OR (95%CI)
Betel Quid 
Chewing
HBV/or 
HCV
No. of 
subjects
No. of 
subjects
No. of 
subjects
No. of 
subjects
No - 1005 1.0 135 0.9 (0.6–1.2) 40 0.5 (0.3–0.8) 23 0.3 (0.1–0.8)
+ 318 1.3 (1.2–1.5) 18 1.6 (1.2–1.9) 21 1.8 (1.3–2.3) 24 2.3 (2.1–2.7)
Yes - 935 1.1 (0.8–1.5) 31 1.3 (1.1–1.3) 23 1.5 (1.2–1.9) 28 1.7 (1.4–2.1)
+ 256 1.5 (1.2–1.8) 36 2.3 (1.9–2.6) 52 3.1 (2.5–3.6) 65 4.2 (3.5–4.7)
HBV: HBsAg(+)
HCV: hepatitis C virus infection
+: positive
-: negative
OR(95%): odds ratio(95%CI)
1 ×: upper normal limit
1–3 ×: one to three times of upper normal limit
5 ×: five times of upper normal limitBMC Gastroenterology 2008, 8:13 http://www.biomedcentral.com/1471-230X/8/13
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and 2.1 times, respectively. Betel quid chewing was inde-
pendently associated with cirrhosis of liver, with an
adjusted OR of 1.7 (95 % C.I., 1.2–2.3).
Discussion
Although the frequencies of abnormal ALT, AST, and GGT
among Aboriginal were found to be all above 18% and
significantly higher than in non-Aboriginal (all p's <
0.001), such associations might not be necessarily causal,
especially using a cross-sectional design, requires careful
evaluation. In this study, most people in this Aboriginal
community were employed by industry related to tourism
and sightseeing. It also attracted a lot of non-Aboriginal
people to work and reside in the community and pro-
vided us an excellent opportunity to compare the findings
in these ethnic groups. In fact, the proportions of betel
quid chewers among Aboriginals (48.2%) and non-Abo-
riginals (12.8%) estimated from this study were similar to
those reported before [12,16], indicating a relatively rep-
resentative sample from both ethnic groups. Since the
coverage proportions of National Health Insurance for
non-Aboriginal and Aboriginal people of this community
were about 97% and 93 %, respectively, and both of them
were waived from partial co-payment, the likelihood of
selection bias seems very low.
After controlling all known risk factors for liver diseases
(including viral infections, smoking, alcohol drinking,
overweight, gender and ethnicity), there was still 1.3 – 1.5
times of increased odds ratio in Aboriginal. Thus, the asso-
ciation deserves our further consideration. There were fol-
lowing possible random errors on measurements of
determinants: The history of ethnic group was generally
very accurate because only Aboriginals were entitled to a
complete waiver for partial co-payment if treated by a doc-
tor. The BMI of every subject was calculated by a nurse
immediately after physical measurements of body weight
and height. Thus, only the history of alcohol drinking,
smoking and betel quid chewing might have a chance to
be randomly misclassified, which usually lead toward the
null or underestimation.
Except for the unknown factors that might cause non-ran-
dom errors, our multivariate models controlled for all the
known major risk factors, including viral hepatitis B and
C, current alcohol drinking and/or cigarette smoking, and
increased BMI were found to be independently associated
with abnormal elevation of liver transaminase as shown
in Tables 2 and 4. Moreover, all these factors except
increased BMI were also found to be associated with liver
cirrhosis diagnosed through ultrasonography, which fur-
ther increased the credibility of this study. Therefore, we
concluded that biochemical dysfunction of liver may be
independently affected by the above risk factors, includ-
ing betel chewing. Tables 3 and 4 seemed to indicate that
persistent elevation of liver transaminases could be an
early sign of chronic inflammation that might result in the
liver cirrhosis. But we should not make too strong infer-
ence because of the limited number of cases and lack of
biopsy proof.
Therefore, we concluded that biochemical dysfunction of
liver may be independently affected by the above risk fac-
tors, including betel chewing. Efforts to reduce the preva-
lence of liver disease in Aboriginal should, therefore,
include efforts to increase quitting of the betel habit.
The above findings deserve to examine possible causal
mechanism between betel quid chewing and liver injury.
Areca nut was reported to immunologically suppress body
defense to HBV/HCV infection [34] and increase the risk
of toxic hepatitis[31,32], which might be related to other
reactive oxygen adducts formed as a result of habitual
betel chewing [35,36]. An alternative explanation might
be the high proportion (up to 37.5%) of betel quids con-
taminated by aflatoxin [37], which is a well-documented
hepatotoxin [38,39]. Further studies are needed to deter-
mine which components of betel quids may be responsi-
ble for liver damage are now required.
Table 4: Adjusted odds ratio(OR) and 95%CI (confidence 
interval) from multiple logistic regression for risk factors of 
cirrhosis of liver diagnosed by ultrasonography
Variables No. of liver cirrhosis/total OR (95%CI)
No. of Cases 41/1382 (3.0%)
Ethnic group
Non-Aboriginal 7/398 (1.8%) 1.0
Aboriginal 34/984 (3.5%) 1.8(1.4–3.6)
Alcohol drinking
Never 2/681(0.3%) 1.0
Former 6/101(5.9%) 1.6(1.3–4.6)
Current 33/600(5.5%) 2.1(1.5–3.5)
Cigarette smoking
Never 9/892(1.0%) 1.0
Former 2/49(4.1%) 1.3(0.6–10.7)
Current 30/441(6.8%) 1.8(1.1–2.7)
Betel quid chewing
No 19/679(3.5%) 1.0
Yes 22/703(2.2%) 1.7(1.2–2.3)
Gender
Female 5/732(0.7%) 1.0
Male 36/650(5.5%) 1.5(1.2–3.9)
BMI
<=25 26/852(3.1%) 1.0
>25 15/530(2.8%) 0.9(0.6–1.7)
HBV/HCV
-/- 21/1020(2.1%) 1.0
+/- 18/300(6.0%) 1.9(0.4–12.8)
-/+ 1/32(3.1%) 2.2(1.4–4.7)
+/+ 1/3(33.3%) 5.4(0.2–7.6)
+:positive; -:negative OR: odds ratioBMC Gastroenterology 2008, 8:13 http://www.biomedcentral.com/1471-230X/8/13
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Although Safrole, listed as a carcinogen by the Environ-
mental Protection Administration, USA, have been iso-
lated from areca nut [34], the phenolic compounds in
betel leaf might be antimutagenic [40,41] or possibly pro-
tective against carcinogens [42]. Thus, it is difficult to
hypothesize. As there were 86% smokers and 75% drink-
ers in Chinese betel chewers [14], the possible mecha-
nisms and interactions among smoking, drinking, and
betel chewing deserved further studies on the develop-
ment of liver cirrhosis.
Conclusion
The shortened life expectancy in Aboriginal people of Tai-
wan has long been noticed since the early 1980's [1]. The
issue has attracted public concern after democratization of
Taiwan. Recently, the government of Taiwan has put a lot
of efforts to improve Aboriginal health for the reason of
equity and justice. The funding of this study was part of
such efforts to determine the major risk factors and prev-
alence rates of various diseases. The next moves will not
only further increase coverage rates of National Health
Insurance, improve health manpower and accessibility for
healthcare of Aboriginal community in remote area, but
also provide programs for reduction in betel chewing rates
in Aboriginals to effectively prevent liver diseases
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